Olympic Ophthalmics secures FDA approval for iTEAR100 neurostimulator
iTEAR100 is a pocket-size device that activates the parasympathetic nerve pathway that controls tear film homeostasis
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
15 May 20
iTEAR100 is a pocket-size device that activates the parasympathetic nerve pathway that controls tear film homeostasis
12 May 20
The Tsert-SI delivery system includes a pre-loaded telescope implant injector, which reduces the incision size by nearly half
08 May 20
The Omni surgical system is a manually operated device developed to deliver small amounts of viscoelastic fluid
30 Apr 20
Two-year final results from STAR-I trial and initial data from STAR-II European trial tout MINIject as a highly…
20 Apr 20
Amblyotech applies active gaming and passive video technology with 3-D glasses to train the eyes to work together…
03 Apr 20
To boost the reform of China's medical device approval process and explore the value of the Real World…
11 Mar 20
The multicentre, retrospective interventional clinical study involved 46 eyes in 41 patients, with a median age of 12…
27 Feb 20
MicroPulse P3 device has been redesigned to deliver better stability, visualisation, coupling and fit
19 Feb 20
LumiThera was granted a CE mark to commercialize the Valeda System in European Union for the treatment of…
30 Jan 20
IRIS is one of six initial grantees for the AI for Health initiative and is honoured to be…